Clinical Features of Vitiligo Linked to Age of Disease Onset

Share this content:
Clinical Features of Vitiligo Linked to Age of Disease Onset
Clinical Features of Vitiligo Linked to Age of Disease Onset

MONDAY, Jan. 9, 2017 (HealthDay News) -- The clinical features of vitiligo are associated with age of disease onset, according to a study published online Jan. 4 in the International Journal of Dermatology.

Berna Solak, M.D., from Sakarya University in Turkey, and colleagues examined the demographic and clinical features of patients with non-segmental vitiligo and the correlation between vitiligo and autoimmune diseases. Data were retrospectively evaluated for 224 vitiligo patients with complete medical records.

The researchers found that children had significantly higher prevalence of halo nevi than among other patient groups. Adults with adult-onset disease had higher prevalence of leukotrichia than pediatric patients or adults with childhood-onset disease. Adults with adult-onset disease had significantly higher levels of anti-thyroglobulin (TG) and anti-thyroid peroxidase than pediatric patients and adults with childhood-onset disease. Autoimmune disease prevalence was 22.2 percent. Patients with treatment-related regimentation had significantly higher anti-TG levels than those without repigmentation.

"This study shows that clinical features and associations with autoimmune disease may vary according to the age of onset of vitiligo," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »